EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bradycardia in Athletes: Prevalence, Mechanisms, and Risks

Paolo D'Ambrosio iD, Jarne De Paepe iD, Luke W Spencer iD, Monique Ohanian iD, Kristel Janssens iD, Amy M Mitchell iD, M Darragh Flannery, Youri Bekhuis iD, Rik Pauwels iD, Boris Delpire, Christophe Dausin, Stephanie J Rowe iD und 17 weitere

Circulation · 03.03.2026 · 153 (9) · 616-630

DOI: 10.1161/circulationaha.125.076170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 03.03.2026. Verfasst von Paolo D'Ambrosio und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, The University of Melbourne, Parkville, VIC, Australia (P.D., L.W.S., A.M.M., M.D.F., S.J.R., P.M.K., J.M.K., A.L.G.). Hauptthemen laut MEDLINE: Bradycardia, Athletes, Heart Rate. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sinus bradycardia is a well-recognized physiological adaptation in endurance athletes, primarily attributed to sinus node remodeling or increased vagal modulation. Although genetic influences on resting heart rate (HR) have been observed, the genetic contribution to athletic bradycardia has not been elucidated. METHODS: We phenotyped current and former elite endurance athletes in the Pro@Heart cohort study using multimodal cardiac imaging, cardiopulmonary exercise testing, and Holter monitoring. Genetic susceptibility to bradycardia was assessed using a validated HR-associated polygenic risk score (HR-PRS), in which lower scores are associated with a lower HR, and compared with healthy nonathletic controls. Clinical and genetic features of bradycardic endurance athletes with minimum HR ≤40 bpm on a Holter monitor (bradycardic athletes [BAs]) were compared with non-BAs). A healthy cohort of nonathletes from the ASPREE study (Aspirin in Reducing Events in the Elderly) were used for genetic comparisons. RESULTS: Among 465 endurance athletes (median age, 23 [18–49] years, 75% men), 175 (38%) had a minimum HR on a Holter monitor ≤40 bpm, of whom 7 (2% of total) had a HR ≤30bpm. Pauses ≥2 s were observed in 115 (25%) athletes, of whom 12 (3% of total) had pauses ≥3 s. Mobitz I second-degree atrioventricular block was observed in 15 (3% of total) athletes. BAs were younger and fitter and exhibited greater athletic cardiac remodeling than non-BAs. Mean HR-PRS was significantly lower in all athletes compared with ASPREE nonathletes ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BradycardiaAthletesHeart RateHumansMaleFemaleAdultMiddle AgedPrevalenceYoung AdultAdolescentElectrocardiography, AmbulatoryRisk FactorsGenetic Predisposition to DiseasePhysical EnduranceCohort Studies

Stichwörter der Autor:innen

AV blockarrhythmiasathletesbradycardiadiagnostic imagingexercisegeneticsheart rate

Autor:innen und Institutionen

  • Department of Medicine, The University of Melbourne, Parkville, VIC, Australia (P.D., L.W.S., A.M.M., M.D.F., S.J.R., P.M.K., J.M.K., A.L.G.).
  • Heart, Exercise and Research Trials Lab, St Vincent's Institute, Fitzroy, VIC, Australia (P.D., L.W.S., K.J., A.M.M., M.D.F., S.J.R., A.L.G.).
  • Department of Cardiology, John Hunter Hospital, New Lambton Heights, NSW, Australia (P.D., G.M.M.).
  • Departments of Cardiovascular Sciences (J.D.P., Y.B., R.P., B.D., T.V.P., T.R., R.W., G.C.), KU Leuven, Leuven, Belgium.
  • Department of Cardiology, University Hospitals Leuven, Leuven, Belgium (J.D.P., Y.B., R.P., B.D., T.R., R.W.).
  • Department of Cardiology, Hartcentrum, Jessa Ziekenhuis, Hasselt, Belgium (J.D.P., Y.B., R.P., B.D., G.C.).

ORCID-Profile: Paolo D'Ambrosio, Jarne De Paepe, Luke W Spencer, Monique Ohanian, Kristel Janssens, Amy M Mitchell, Youri Bekhuis, Rik Pauwels, Stephanie J Rowe, Tim Van Puyvelde, Paul E Young, Magdalena J Soka, Renee Johnson, Chenglong Yu, Tomas Robyns, Paul Lacaze, Eleni Giannoulatou, Peter M Kistler, Jonathan M Kalman, Hein Heidbuchel, Rik Willems, Diane Fatkin, André La Gerche

Zitieren

APA

D'Ambrosio, P., De Paepe, J., Spencer, L. W., Ohanian, M., Janssens, K., Mitchell, A. M., Flannery, M. D., Bekhuis, Y., Pauwels, R., Delpire, B., Dausin, C., Rowe, S. J., Van Puyvelde, T., Young, P. E., Soka, M. J., Johnson, R., Yu, C., Morris, G. M., Robyns, T., …, & Pro@Heart Consortium (2026). Bradycardia in Athletes: Prevalence, Mechanisms, and Risks. Circulation, 153(9), 616-630. https://doi.org/10.1161/circulationaha.125.076170

Vancouver

D'Ambrosio P, De Paepe J, Spencer LW, Ohanian M, Janssens K, Mitchell AM, et al. Bradycardia in Athletes: Prevalence, Mechanisms, and Risks. Circulation. 2026;153(9):616-630. doi:10.1161/circulationaha.125.076170

BibTeX
@article{DAmbrosio2026,
  author = {D'Ambrosio, Paolo and De Paepe, Jarne and Spencer, Luke W and Ohanian, Monique and Janssens, Kristel and Mitchell, Amy M and Flannery, M Darragh and Bekhuis, Youri and Pauwels, Rik and Delpire, Boris and Dausin, Christophe and Rowe, Stephanie J and Van Puyvelde, Tim and Young, Paul E and Soka, Magdalena J and Johnson, Renee and Yu, Chenglong and Morris, Gwilym M and Robyns, Tomas and Lacaze, Paul and Giannoulatou, Eleni and Kistler, Peter M and Kalman, Jonathan M and Heidbuchel, Hein and Willems, Rik and Claessen, Guido and Fatkin, Diane and La Gerche, André and Pro@Heart Consortium, Pro@Heart Consortium},
  title = {Bradycardia in Athletes: Prevalence, Mechanisms, and Risks},
  journal = {Circulation},
  year = {2026},
  volume = {153},
  number = {9},
  pages = {616--630},
  doi = {10.1161/circulationaha.125.076170}
}
Kostenlos starten →